Assuta Hospital is a trusted healthcare provider for Rhabdomyosarcoma (RMS) Treatment, offering multidisciplinary care for pediatric and young patients with cancer, supported by experienced oncologists and modern medical infrastructure. Established in 1934, the JCI hospital is situated in Tel Aviv, Israel and has 300 beds.

Rhabdomyosarcoma (RMS) Treatment is chosen according to the tumor's location, stage, risk group, and overall health of the patient. Chemotherapy is an important component of treatment and may be combined with surgery and radiation therapy to achieve local and systemic disease control. In some cases, specialized treatment may be considered for recurrent or high-risk disease. Comprehensive diagnostic evaluation and regular imaging help doctors monitor treatment response and detect changes during follow-up.